• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

P-糖蛋白的功能作用及结合蛋白对洛匹那韦/利托那韦在离体人灌注模型中胎盘转运的影响

Functional role of p-glycoprotein and binding protein effect on the placental transfer of lopinavir/ritonavir in the ex vivo human perfusion model.

作者信息

Ceccaldi Pierre-Francois, Gavard Laurent, Mandelbrot Laurent, Rey Elisabeth, Farinotti Robert, Treluyer Jean-Marc, Gil Sophie

机构信息

Department of Obstetrics and Gynecology, Louis Mourier Hospital, AP-HP, Paris 7 University, 92701 Colombes, France.

出版信息

Obstet Gynecol Int. 2009;2009:726593. doi: 10.1155/2009/726593. Epub 2009 May 18.

DOI:10.1155/2009/726593
PMID:19960055
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2778444/
Abstract

Aims. To study the influence of P-glycoprotein (P-glycoprotein, ABCB1, MDR1) function on placental transfer of lopinavir with ritonavir at different albumin concentrations. Methods. Cotyledons were perfused with lopinavir, ritonavir, and the internal control antipyrin, at various albumin concentrations (10, 30, 40 g/L). After the control phase of each experiment, the P-glycoprotein inhibitor ciclosporin A was added at middle perfusion (45 minutes). Fetal Transfer Rate (FTR) and Clearance Index (CLI) were compared between the 2 phases. Results. In the control phase, the clearance index of lopinavir decreased from 0.401 +/- 0.058 to 0.007 +/- 0.027, as albumin concentrations increased from 10 g/L to higher concentrations (30, 40 g/L). When adding ciclosporin A at physiological albumin concentrations, the clearance index of lopinavir increased significantly 10.3 fold (95% of CI difference [-0.156, -0.002], P = .046) and became positive for ritonavir. Conclusions. Even at high albumin concentrations, inhibition of placental P-glycoprotein increased placental transfer of lopinavir, suggesting that this efflux pump actively reduces placental transfer of the drug. This mechanism may play a role in fetal exposure to maternal antiretroviral therapy.

摘要

目的。研究P-糖蛋白(P-糖蛋白,ABCB1,MDR1)功能在不同白蛋白浓度下对洛匹那韦与利托那韦胎盘转运的影响。方法。在不同白蛋白浓度(10、30、40 g/L)下,用洛匹那韦、利托那韦和内对照安替比林灌注胎盘小叶。在每个实验的对照阶段后,在灌注中期(45分钟)加入P-糖蛋白抑制剂环孢素A。比较两个阶段的胎儿转运率(FTR)和清除指数(CLI)。结果。在对照阶段,随着白蛋白浓度从10 g/L增加到更高浓度(30、40 g/L),洛匹那韦的清除指数从0.401±0.058降至0.007±0.027。在生理白蛋白浓度下加入环孢素A时,洛匹那韦的清除指数显著增加10.3倍(95%CI差异[-0.156,-0.002],P = 0.046),利托那韦的清除指数变为正值。结论。即使在高白蛋白浓度下,抑制胎盘P-糖蛋白也会增加洛匹那韦的胎盘转运,表明这种外排泵会主动降低药物的胎盘转运。这种机制可能在胎儿暴露于母体抗逆转录病毒治疗中起作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011d/2778444/fac38ca22cfa/OGI2009-726593.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011d/2778444/f999faef7c57/OGI2009-726593.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011d/2778444/52266a5a8f9e/OGI2009-726593.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011d/2778444/fac38ca22cfa/OGI2009-726593.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011d/2778444/f999faef7c57/OGI2009-726593.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011d/2778444/52266a5a8f9e/OGI2009-726593.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/011d/2778444/fac38ca22cfa/OGI2009-726593.003.jpg

相似文献

1
Functional role of p-glycoprotein and binding protein effect on the placental transfer of lopinavir/ritonavir in the ex vivo human perfusion model.P-糖蛋白的功能作用及结合蛋白对洛匹那韦/利托那韦在离体人灌注模型中胎盘转运的影响
Obstet Gynecol Int. 2009;2009:726593. doi: 10.1155/2009/726593. Epub 2009 May 18.
2
Placental transfer of lopinavir/ritonavir in the ex vivo human cotyledon perfusion model.洛匹那韦/利托那韦在体外人胎盘小叶灌注模型中的胎盘转运。
Am J Obstet Gynecol. 2006 Jul;195(1):296-301. doi: 10.1016/j.ajog.2006.01.017. Epub 2006 May 5.
3
Binding of lopinavir to human alpha1-acid glycoprotein and serum albumin.洛匹那韦与人α1-酸性糖蛋白和血清白蛋白的结合。
Drug Metab Dispos. 2009 Aug;37(8):1572-5. doi: 10.1124/dmd.109.026708. Epub 2009 May 13.
4
ABCB1 polymorphisms and the concentrations of lopinavir and ritonavir in blood, semen and saliva of HIV-infected men under antiretroviral therapy.接受抗逆转录病毒治疗的HIV感染男性中ABCB1基因多态性与洛匹那韦和利托那韦在血液、精液及唾液中的浓度
Pharmacogenomics. 2009 Feb;10(2):311-8. doi: 10.2217/14622416.10.2.311.
5
Lopinavir/ritonavir treatment increases the placental transfer of bupivacaine enantiomers in human immunodeficiency virus-infected pregnant women.洛匹那韦/利托那韦治疗增加了人类免疫缺陷病毒感染孕妇布比卡因对映体向胎盘的转移。
Br J Clin Pharmacol. 2018 Oct;84(10):2415-2421. doi: 10.1111/bcp.13700. Epub 2018 Aug 2.
6
Functional role of P-glycoprotein in the human blood-placental barrier.P-糖蛋白在人血-胎盘屏障中的功能作用。
Clin Pharmacol Ther. 2005 Aug;78(2):123-31. doi: 10.1016/j.clpt.2005.04.014.
7
Contribution and limit of the model of perfused cotyledon to the study of placental transfer of drugs. Example of a protease inhibitor of HIV: nelfinavir.灌流胎盘中药物转运模型的贡献与局限性。以 HIV 蛋白酶抑制剂奈非那韦为例。
Eur J Obstet Gynecol Reprod Biol. 2009 Dec;147(2):157-60. doi: 10.1016/j.ejogrb.2009.08.007. Epub 2009 Sep 20.
8
Effects of cytochrome P450 3A (CYP3A) and the drug transporters P-glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) on the pharmacokinetics of lopinavir.细胞色素 P450 3A(CYP3A)以及药物转运蛋白 P-糖蛋白(MDR1/ABCB1)和多药耐药相关蛋白 2(MRP2/ABCC2)对洛匹那韦药代动力学的影响。
Br J Pharmacol. 2010 Jul;160(5):1224-33. doi: 10.1111/j.1476-5381.2010.00759.x.
9
Effect of an antiretroviral regimen containing ritonavir boosted lopinavir on intestinal and hepatic CYP3A, CYP2D6 and P-glycoprotein in HIV-infected patients.含利托那韦增强洛匹那韦的抗逆转录病毒方案对HIV感染患者肠道和肝脏中CYP3A、CYP2D6及P-糖蛋白的影响
Clin Pharmacol Ther. 2008 Jul;84(1):75-82. doi: 10.1038/sj.clpt.6100452. Epub 2008 Jan 9.
10
Placental transfer of ritonavir with zidovudine in the ex vivo placental perfusion model.在体外胎盘灌注模型中利托那韦与齐多夫定的胎盘转运。
Am J Obstet Gynecol. 1998 Sep;179(3 Pt 1):758-61. doi: 10.1016/s0002-9378(98)70078-x.

引用本文的文献

1
Fetus Exposure to Drugs and Chemicals: A Holistic Overview on the Assessment of Their Transport and Metabolism across the Human Placental Barrier.胎儿对药物和化学物质的暴露:关于评估其在人胎盘屏障中的转运和代谢的全面概述。
Diseases. 2024 Jun 1;12(6):114. doi: 10.3390/diseases12060114.
2
Outcomes of Children with Fetal and Lactation Immunosuppression Exposure Born to Female Transplant Recipients.女性器官移植受者所生的胎儿和哺乳期免疫抑制暴露儿童的结局。
Paediatr Drugs. 2022 Sep;24(5):483-497. doi: 10.1007/s40272-022-00525-y. Epub 2022 Jul 23.
3
A Glyphosate-Based Formulation but Not Glyphosate Alone Alters Human Placental Integrity.

本文引用的文献

1
Inhibition of placental P-glycoprotein: impact on indinavir transfer to the foetus.胎盘P-糖蛋白的抑制作用:对茚地那韦向胎儿转运的影响。
Br J Clin Pharmacol. 2008 May;65(5):667-73. doi: 10.1111/j.1365-2125.2007.03067.x. Epub 2007 Dec 17.
2
Both P-gp and MRP2 mediate transport of Lopinavir, a protease inhibitor.P-糖蛋白和多药耐药相关蛋白2均介导蛋白酶抑制剂洛匹那韦的转运。
Int J Pharm. 2007 Jul 18;339(1-2):139-47. doi: 10.1016/j.ijpharm.2007.02.036. Epub 2007 Mar 6.
3
Reduced lopinavir exposure during pregnancy.孕期洛匹那韦暴露减少。
基于草甘膦的配方制剂而非草甘膦本身会改变人胎盘的完整性。
Toxics. 2021 Sep 13;9(9):220. doi: 10.3390/toxics9090220.
4
Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019.在妊娠期研究用于治疗 2019 冠状病毒病的药物的胎盘转运和安全性。
Am J Obstet Gynecol MFM. 2020 Aug;2(3):100159. doi: 10.1016/j.ajogmf.2020.100159. Epub 2020 Jun 22.
5
Placental transfer and tissue accumulation of dolutegravir in the ex vivo human cotyledon perfusion model.多替拉韦在离体人胎盘绒毛叶灌流模型中的胎盘转运和组织蓄积。
PLoS One. 2019 Aug 13;14(8):e0220323. doi: 10.1371/journal.pone.0220323. eCollection 2019.
6
Lopinavir/ritonavir treatment increases the placental transfer of bupivacaine enantiomers in human immunodeficiency virus-infected pregnant women.洛匹那韦/利托那韦治疗增加了人类免疫缺陷病毒感染孕妇布比卡因对映体向胎盘的转移。
Br J Clin Pharmacol. 2018 Oct;84(10):2415-2421. doi: 10.1111/bcp.13700. Epub 2018 Aug 2.
7
The Role of PXR Genotype and Transporter Expression in the Placental Transport of Lopinavir in Mice.孕烷X受体基因型和转运体表达在小鼠中洛匹那韦胎盘转运中的作用
Pharmaceutics. 2017 Oct 24;9(4):49. doi: 10.3390/pharmaceutics9040049.
8
Maternal use of drug substrates of placental transporters and the effect of transporter-mediated drug interactions on the risk of congenital anomalies.母亲使用胎盘转运蛋白的药物底物以及转运蛋白介导的药物相互作用对先天性异常风险的影响。
PLoS One. 2017 Mar 13;12(3):e0173530. doi: 10.1371/journal.pone.0173530. eCollection 2017.
9
Placental Origins of Chronic Disease.慢性病的胎盘起源
Physiol Rev. 2016 Oct;96(4):1509-65. doi: 10.1152/physrev.00029.2015.
10
P-Glycoprotein-Mediated Drug Interactions in Pregnancy and Changes in the Risk of Congenital Anomalies: A Case-Reference Study.孕期P-糖蛋白介导的药物相互作用与先天性异常风险变化:一项病例对照研究。
Drug Saf. 2015 Jul;38(7):651-9. doi: 10.1007/s40264-015-0299-3.
AIDS. 2006 Oct 3;20(15):1931-9. doi: 10.1097/01.aids.0000247114.43714.90.
4
Differential protein binding of indinavir and saquinavir in matched maternal and umbilical cord plasma.茚地那韦和沙奎那韦在配对的母体和脐带血浆中的差异蛋白结合
Br J Clin Pharmacol. 2007 Mar;63(3):315-21. doi: 10.1111/j.1365-2125.2006.02766.x. Epub 2006 Sep 19.
5
Placental transfer of lopinavir/ritonavir in the ex vivo human cotyledon perfusion model.洛匹那韦/利托那韦在体外人胎盘小叶灌注模型中的胎盘转运。
Am J Obstet Gynecol. 2006 Jul;195(1):296-301. doi: 10.1016/j.ajog.2006.01.017. Epub 2006 May 5.
6
P-glycoprotein in the placenta: expression, localization, regulation and function.胎盘中的P-糖蛋白:表达、定位、调控及功能
Reprod Toxicol. 2006 Oct;22(3):400-10. doi: 10.1016/j.reprotox.2006.01.007. Epub 2006 Mar 24.
7
Increased expression of MDR1 mRNAs and P-glycoprotein in placentas from HIV-1 infected women.HIV-1感染女性胎盘组织中MDR1 mRNA和P-糖蛋白表达增加。
Placenta. 2006 Jun-Jul;27(6-7):699-706. doi: 10.1016/j.placenta.2005.08.001. Epub 2005 Sep 12.
8
Functional role of P-glycoprotein in the human blood-placental barrier.P-糖蛋白在人血-胎盘屏障中的功能作用。
Clin Pharmacol Ther. 2005 Aug;78(2):123-31. doi: 10.1016/j.clpt.2005.04.014.
9
Differential bidirectional transfer of indinavir in the isolated perfused human placenta.茚地那韦在离体灌注人胎盘中的差异双向转运
Antimicrob Agents Chemother. 2005 Mar;49(3):1023-8. doi: 10.1128/AAC.49.3.1023-1028.2005.
10
P-glycoprotein expression of the human placenta during pregnancy.孕期人胎盘的P-糖蛋白表达
Placenta. 2005 Feb-Mar;26(2-3):268-70. doi: 10.1016/j.placenta.2004.05.013.